Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | APAF1 | O14727 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | CASP1 | P29466 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 7/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28148524 | 0.97 | ALDH1A1 (0.64) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| SCHEMBL28713 | 0.97 | — | — | |
| Ethane SCHEMBL16114596 | 0.94 | ALDH1A1 (0.61) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| SCHEMBL27808383 | 0.94 | ALDH1A1 (0.61) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| Water SCHEMBL28098300 | 0.94 | ALDH1A1 (0.61) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| SCHEMBL27587206 | 0.94 | ALDH1A1 (0.61) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| SCHEMBL27712317 | 0.94 | ALDH1A1 (0.61) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| SCHEMBL27541364 | 0.94 | ALDH1A1 (0.61) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| Hydrochloric Acid SCHEMBL7071404 | 0.94 | ALDH1A1 (0.61) | ALDH1A1HSD17B10MEN1MAPTHPGD | |
| Ammonia Solution, Strong SCHEMBL324960 | 0.92 | ALDH1A1 (0.55) | ALDH1A1HSD17B10MEN1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160053040-A1 | REINFORCING AGENT FOR POLYCARBONATE RESIN, POLYCARBONATE RESIN COMPOSITION, AND MOLDED ARTICLE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-02-25 | — | — | US | disclosed |
| US-8431378-B2 | Aminotransferase, gene encoding the same, and methods of using them | KANEKA CORPORATION (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20120164724-A1 | NOVEL AMINOTRANSFERASE, GENE ENCODING THE SAME, AND METHODS OF USING THEM | KANEKA CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
| US-8133705-B2 | Aminotransferase, gene encoding the same, and method of using them | KANEKA CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100285544-A1 | Novel aminotransferase, gene encoding the same, and method of using them | KANEKA CORPORATION (JP) | 2010-11-11 | — | — | US | disclosed |
| EP-1889907-B1 | NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME | KANEKA CORP (JP) | 2009-09-02 | — | — | EP | disclosed |
| EP-1045025-B1 | (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE | KANEKA CORP (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1889907-A1 | NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME | Kaneka Corporation (JP) | 2008-02-20 | — | — | EP | disclosed |
| US-6346402-B1 | ACTS ON OPTICALLY ACTIVE (S)-ALPHA-PHENETHYLAMINE AND PYRUVIC ACID TO FORM ACETOPHENONE AND ALANINE; FOR PRODUCING CHEMICAL INTERMEDIATES OF DRUGS AND AGRICULTURAL CHEMICALS | KANEKA CORPORATION (JP) | 2002-02-12 | — | — | US | disclosed |
| EP-1045025-A1 | (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE | KANEKA CORPORATION (JP) | 2000-10-18 | — | — | EP | disclosed |
| EP-0563132-A1 | TETRAPEPTIDE DERIVATIVES AND ANALOGUES. | BLACK JAMES FOUNDATION (GB) | 1993-10-06 | — | — | EP | disclosed |
| EP-0077202-B1 | PROCESS FOR HYDROXYLATING OLEFINS USING OSMIUM-HALOGEN COMPOUND CATALYSTS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-04-09 | — | — | EP | disclosed |
| EP-0077201-B1 | HYDROXYLATION OF OLEFINS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-01-15 | — | — | EP | disclosed |
| US-4486613-A | CATALYTIC OXIDATION | EXXON RESEARCH & ENGINEERING CO. (US) | 1984-12-04 | — | — | US | disclosed |
| EP-0104873-A2 | A process for hydroxylating olefins using an osmium carbonyl catalyst | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-04-04 | — | — | EP | disclosed |
| EP-0102154-A1 | Process for hydroxylating olefins using a supported osmium catalyst | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-03-07 | — | — | EP | disclosed |
| US-4413151-A | WITH WATER AND OXIDIZER | EXXON RESEARCH & ENGINEERING CO. (US) | 1983-11-01 | — | — | US | disclosed |
| US-4390739-A | Hydroxylation of olefins | EXXON RESEARCH & ENGINEERING CO. (US) | 1983-06-28 | — | — | US | disclosed |
| EP-0077202-A2 | Process for hydroxylating olefins using osmium-halogen compound catalysts | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-04-20 | — | — | EP | disclosed |
| EP-0077201-A2 | Hydroxylation of olefins | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-04-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100285544-A1 | Novel aminotransferase, gene encoding the same, and method of using them | BCAT1, AGXT, ALDH7A1 | ALDH1A1 144/4885HSD17B10 118/4885MEN1 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.